WallStreetZenWallStreetZen

NASDAQ: KALA
Kala Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KALA past revenue growth

How has KALA's revenue growth performed historically?
Company
-100%
Industry
37.31%
Market
16.68%
KALA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KALA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KALA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KALA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$38.7M
Current Profit Margin
0%

KALA Return on Equity

Current Company
-396%
Current Industry
11.7%
Current Market
34.1%
KALA's Return on Equity (-396%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KALA announces earnings.

KALA Return on Assets

Current Company
-66.8%
Current Industry
4.2%
KALA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KALA Return on Capital Employed

Current Company
-77.51%
Current Industry
11.6%
KALA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KALA vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KALA$0.00-$32.28M-$38.72M-100.00%N/A
IXHLN/AN/AN/AN/AN/A
TXMD$996.00k-$5.14M-$6.09M-44.31%N/A
BGXX$0.00-$9.31M-$9.92MN/AN/A
CYTH$1.13M-$20.72M-$20.74M+3.40%N/A
View Top Pharmaceutical Stocks

Kala Bio Earnings & Revenue FAQ

What were KALA's earnings last quarter?

On Invalid Date, Kala Bio (NASDAQ: KALA) reported Q2 2024 earnings per share (EPS) of -$3.16, up 27.52% year over year. Total Kala Bio earnings for the quarter were -$9.58 million. In the same quarter last year, Kala Bio's earnings per share (EPS) was -$4.36.

If you're new to stock investing, here's how to buy Kala Bio stock.

What was KALA's earnings growth in the past year?

As of Q3 2024, Kala Bio's earnings has grown year over year. Kala Bio's earnings in the past year totalled -$38.72 million.

What was KALA's revenue last quarter?

On Invalid Date, Kala Bio (NASDAQ: KALA) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Kala Bio's revenue was $0.00.

What was KALA's revenue growth in the past year?

As of Q3 2024, Kala Bio's revenue has grown -100% year over year. This is 137.31 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 37.31%. Kala Bio's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.